Optimization of protocols for derivation of mouse embryonic stem cell lines from refractory strains, including the

Timothy J Davies1, Paul J Fairchild

  • 1Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.

Stem Cells and Development
|September 22, 2011
PubMed

Insights

Researchers developed a new method to derive embryonic stem cells (ESCs) from difficult mouse strains, including the non obese diabetic (NOD) mouse. This breakthrough facilitates disease modeling and genetic studies in diverse mouse models.

Area of Science:

  • Stem Cell Biology
  • Developmental Biology
  • Genetics

Background:

  • Deriving embryonic stem cells (ESCs) from diverse mouse genetic backgrounds is crucial for disease modeling and functional genomics.
  • Generating bona fide ESCs from certain mouse strains, like the non obese diabetic (NOD) strain, has been historically challenging.

Purpose of the Study:

  • To develop and optimize protocols for deriving ESCs from genetically challenging mouse strains.
  • To establish a robust method for generating ESCs applicable to both permissive and nonpermissive mouse models, including the NOD mouse.

Main Methods:

  • Utilized high concentrations of leukemia inhibitory factor (LIF) combined with serum replacement for ESC derivation.
  • Applied the protocol to fresh and cryopreserved embryos from C57Bl/6, Balb/K, CBA/Ca, and NOD mice.
  • Assessed ESC pluripotency, karyotype stability, in vivo teratoma formation, germline transmission in chimeras, and in vitro differentiation potential.

Main Results:

  • Successfully derived novel ESC lines from C57Bl/6, Balb/K, CBA/Ca, and notably, the previously refractory NOD mice.
  • NOD ESCs exhibited stable normal karyotypes, formed teratomas, produced germline-competent chimeras, and differentiated into embryoid bodies and dendritic cells.
  • CBA/Ca ESCs demonstrated significant contribution to somatic germ layers and high germline transmission competence.

Conclusions:

  • The developed protocol effectively enables the derivation of pluripotent ESCs from genetically diverse and previously nonpermissive mouse strains, including NOD mice.
  • These novel ESC lines are valuable tools for modeling human diseases like type I diabetes and for generating specific cell types for research.
  • The protocol's applicability to cryopreserved embryos enhances its utility for broad research applications.

Related Concept Videos